214 related articles for article (PubMed ID: 24835198)
41. Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.
Nagesh HN; Suresh A; Sairam SD; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Sep; 84():605-13. PubMed ID: 25062011
[TBL] [Abstract][Full Text] [Related]
42. Antimycobacterial activity of some pyrido-1,2-thiazine derivatives.
Malinka W; Redzicka A; Swiatek P
Acta Pol Pharm; 2002; 59(6):439-42. PubMed ID: 12669767
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.
Ma X; Tan ST; Khoo CL; Sim HM; Chan LW; Chui WK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5428-31. PubMed ID: 21788136
[TBL] [Abstract][Full Text] [Related]
44. Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
Ponnuchamy S; Kanchithalaivan S; Ranjith Kumar R; Ali MA; Choon TS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1089-93. PubMed ID: 24472146
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
[TBL] [Abstract][Full Text] [Related]
46. Antimycobacterial activity of pyrimido[4,5-b]diazepine derivatives.
Insuasty B; García A; Bueno J; Quiroga J; Abonia R; Ortiz A
Arch Pharm (Weinheim); 2012 Sep; 345(9):739-44. PubMed ID: 22730136
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and antimycobacterial activity of N-(2-aminopurin-6-yl) and N-(purin-6-yl) amino acids and dipeptides.
Krasnov VP; Vigorov AY; Musiyak VV; Nizova IA; Gruzdev DA; Matveeva TV; Levit GL; Kravchenko MA; Skornyakov SN; Bekker OB; Danilenko VN; Charushin VN
Bioorg Med Chem Lett; 2016 Jun; 26(11):2645-8. PubMed ID: 27107949
[TBL] [Abstract][Full Text] [Related]
48. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
49. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and antimycobacterial activity of (+)-usnic acid conjugates.
Cirillo D; Borroni E; Festoso I; Monti D; Romeo S; Mazier D; Verotta L
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800177. PubMed ID: 30407647
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
53. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
54. Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Jardosh HH; Patel MP
Eur J Med Chem; 2013 Jul; 65():348-59. PubMed ID: 23747804
[TBL] [Abstract][Full Text] [Related]
55. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
[TBL] [Abstract][Full Text] [Related]
57. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
Ranjith Kumar R; Perumal S; Senthilkumar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Sep; 44(9):3821-9. PubMed ID: 19524332
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
59. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents.
Upadhayaya RS; Vandavasi JK; Kardile RA; Lahore SV; Dixit SS; Deokar HS; Shinde PD; Sarmah MP; Chattopadhyaya J
Eur J Med Chem; 2010 May; 45(5):1854-67. PubMed ID: 20137835
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1.
Vaitilingam B; Nayyar A; Palde PB; Monga V; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 Aug; 12(15):4179-88. PubMed ID: 15246094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
